Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DA-8031 in Premature Ejaculation
NCT01798667Phase 2Unknown
- Sponsor
- Dong-A Pharmaceutical
- Start
- Jan 2013
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of da-8031 in premature ejaculation (PE), sponsored by Dong-A Pharmaceutical. Status: unknown.
02
Drugs
da-8031
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on NCT01798667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01798667.